Listed

Carlisle Companies Inc: Form 10-Q for the period ended Jun 30, 2022

Filed with the SEC on Jul 28, 2022 and accepted by EDGAR at Jul 28, 2022, 14:50 ET.

Share

Management's discussion and analysis

As filed, 44,538 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Carlisle Companies Incorporated (“Carlisle”, the “Company”, “we”, “us” or “our”) is a leading supplier of innovative building envelope products and energy-efficient solutions for customers creating sustainable buildings of the future. Through our Carlisle Construction Materials ("CCM") and Carlisle Weatherproofing Technologies ("CWT") businesses and family of leading brands, Carlisle delivers innovative, labor-reducing and environmentally responsible products and solutions to customers across the world through the Carlisle Experience. Over the life of a building, Carlisle’s products help drive lower greenhouse gas emissions, improve energy savings for building owners and operators, and increase a building’s resiliency to the elements. Driven by our strategic plan, Vision 2025, Carlisle is committed to generating superior stockholder returns and maintaining a balanced capital deployment approach, including investments in our businesses, strategic acquisitions, share repurchases and continued dividend increases. Carlisle also is a leading provider of products to the aerospace, medical technologies and general industrial markets through its Carlisle Interconnect Technologies ("CIT") and Carlisle Fluid Technologies ("CFT") business segments.

Management’s Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") is designed to provide a reader of our financial statements with a narrative from the perspective of Company management. All references to "Notes" refer to our Notes to Condensed Consolidated Financial Statements in Item 1 of this Quarterly Report on Form 10-Q.

Executive Overview

Carlisle continued our outstanding performance this quarter, especially as we operate in this highly challenging and uncertain environment. Despite these challenges, the Carlisle team continues to live our culture of perseverance, continuous improvement and unwavering focus on delivering results.

As we move past the mid-point of 2022 and reflect on our Vision 2025 strategic plan that we launched in 2018, we are encouraged by our second quarter results. We believe these results clearly demonstrate Carlisle is exceeding expectations and is on pace to achieve much of what we set out to accomplish in Vision 2025, including our goal to deliver $15 of earnings per share.

Achievements in the second quarter included:

  • Our pivot to a more concentrated building products platform continued with the first full quarter of performance for our new CCM and CWT divisions. Both teams experienced a second quarter marked by strong demand, robust backlogs and solid execution;
  • A further reinforcement of our differentiated approach to pricing that reflects the value of the Carlisle Experience, and the benefits of our products that contribute to the energy efficiency of buildings;
  • A continued and disciplined approach to capital allocation, including acquisitions, highlighted by ASP Henry Holdings, Inc. ("Henry"), which continues to exceed expectations and deliver on our synergy commitments of $30 million;
  • Investing in our businesses to expand capacity, drive innovation, and develop world-class capabilities, including:
  • Ongoing construction of our state-of-the-art polyiso insulation facility built to LEED specifications in Sikeston, Missouri, which is on track to be operational in the second quarter of 2023; and
  • Launching of our 6th TPO line in Carlisle, Pennsylvania, which, in September, will introduce to the market an industry-first 16-foot-wide TPO membrane, and is expected to result in significant labor savings, improved installation quality and less packaging waste for our installers;
  • A continued commitment to the introduction of new products, which accounted for over $100 million of revenues in the second quarter;

In the first six months of 2022, we returned $56.7 million in the form of dividends, continuing our 45 year trend of continuous and annually increasing dividends, and repurchased $175.0 million of shares, adding to our cumulative share repurchases since 2017 of nearly $2 billion.

Vision 2025 continues to provide the Carlisle team with the clarity to navigate a complex and rapidly evolving environment, a culture of continuous improvement, and a drive to employ and develop the best talent, all the while ensuring our teams know who we are and what we are trying to achieve. Our outlook remains optimistic for the rest of 2022 and the long term.

Summary of Financial Results

(in millions, except per share amounts)

Three Months Ended June 30, 2022 2021 Six Months Ended June 30, 2022 2021
Revenues $1,846.9 $1,177.8 $3,343.2 $2,118.7
Operating income $410.6 $133.8 $687.9 $218.5
Operating margin 22.2% 11.4% 20.6% 10.3%
Income from continuing operations $295.9 $94.1 $490.2 $143.2
Income from discontinued operations $5.6 $5.2 $4.9 $8.3
Diluted earnings per share attributable to common shares:
Income from continuing operations $5.62 $1.77 $9.28 $2.68
Income from discontinued operations $0.11 $0.10 $0.09 $0.16
Adjusted EBITDA(1) $472.2 $191.7 $817.0 $329.5
Adjusted EBITDA margin(1) 25.6% 16.3% 24.4% 15.6%

(1) Adjusted EBITDA and adjusted EBITDA margin are intended to provide investors and others with information about Carlisle and its segments' performance without the effect of items that, by their nature, tend to obscure core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for more information about, and a detailed reconciliation of these items.

Revenues increased in the second quarter and the first six months of 2022 primarily reflecting positive pricing and higher volumes in all segments and contributions from the acquisition of Henry in the CWT segment, partially offset by unfavorable foreign currency impacts.

The increase in operating margin percentage in the second quarter and the first six months of 2022 primarily reflected positive pricing, higher volumes and favorable product mix, partially offset by raw material and wage inflation across all segments.

Diluted earnings per share from continuing operations increased primarily reflecting improved operating income performance ($3.93 per share in the second quarter of 2022 and $6.64 per share in the first six months of 2022) and reduced average shares outstanding ($0.06 per share in the second quarter of 2022 and $0.11 per share in the first six months of 2022) resulting from purchases under our share repurchase program, partially offset by a higher effective tax rate ($0.08 per share in the second quarter of 2022 and $0.10 per share in the first six months of 2022) and higher interest expense ($0.05 per share in the second quarter of 2022 and $0.09 per share in the first six months of 2022).

We generated $223.5 million in operating cash flow in the first six months of 2022 and utilized cash on hand and cash provided by operations to return capital to stockholders through dividends and share repurchases, and to fund capital expenditures.

Consolidated Results of Operations

Revenues

(in millions)

2022 2021 Change% Acquisition Effect Price / Volume Effect Exchange Rate Effect
Three months ended June 30 $1,846.9 $1,177.8 $669.1 56.8% 15.5% 42.2% (0.9)%
Six months ended June 30 $3,343.2 $2,118.7 $1,224.5 57.8% 15.1% 43.4% (0.7)%

Revenues increased in the second quarter and the first six months of 2022 primarily reflecting positive pricing and higher sales volumes across all segments and contributions from the acquisition of Henry in the CWT segment, partially offset by unfavorable foreign currency impacts.

Gross Margin

(in millions)

2022 Three Months Ended June 30, 2021 Change% 2022 Six Months Ended June 30, 2021 Change%
Gross margin $632.0 $307.7 $324.3 105.4% $1,122.9 $552.6 $570.3 103.2%
Gross margin percentage 34.2% 26.1% 33.6% 26.1%
Depreciation and amortization $25.4 $24.1 $52.4 $48.7

Gross margin percentage (gross margin expressed as a percentage of revenues) increased in the second quarter and the first six months of 2022, driven by positive pricing and higher volumes, partially offset by raw material and wage inflation. Also included in cost of goods sold were exit and disposal costs totaling $1.0 million and $2.9 million for the second quarter and the first six months of 2022, respectively, primarily at CIT attributable to our restructuring initiatives, compared with $3.6 million and $4.4 million for the second quarter and the first six months of 2021, respectively. Refer to Note 8 for further information on exit and disposal activities.

Selling and Administrative Expenses

(in millions)

2022 Three Months Ended June 30, 2021 Change% 2022 Six Months Ended June 30, 2021 Change%
Selling and administrative expenses $210.6 $161.3 $49.3 30.6% $413.6 $312.1 $101.5 32.5%
As a percentage of revenues 11.4% 13.7% 12.4% 14.7%
Depreciation and amortization $36.3 $25.0 $73.6 $49.2

The increase in selling and administrative expenses in the second quarter and the first six months of 2022 primarily reflected incremental costs in the CWT segment from the addition of Henry, higher incentive compensation costs and wage inflation. Also included in selling and administrative expenses were exit and disposal costs totaling $0.1 million and $0.4 million for the second quarter and the first six months of 2022, respectively, primarily at CIT attributable to our restructuring initiatives, compared with $2.8 million and $3.4 million for the second quarter and the first six months of 2021, respectively. Refer to Note 8 for further information on exit and disposal activities.

Research and Development Expenses

(in millions)

2022 Three Months Ended June 30, 2021 Change% 2022 Six Months Ended June 30, 2021 Change%
Research and development expenses $12.6 $13.8 $(1.2) (8.7)% $24.9 $24.2 $0.7 2.9%
As a percentage of revenues 0.7% 1.2% 0.7% 1.1%
Depreciation and amortization $0.8 $0.4 $1.2 $0.9

Research and development expenses were lower in the second quarter of 2022, primarily reflecting lower new product development expenses at our CIT segment. Research and development expenses were higher in the first six months of 2022, primarily reflecting higher new product development expenses at our CWT segment.

Other Operating Income, net

(in millions)

2022 Three Months Ended June 30, 2021 Change% 2022 Six Months Ended June 30, 2021 Change%
Other operating income, net $(1.8) $(1.2) $(0.6) 50.0% $(3.5) $(2.2) $(1.3) 59.1%

Other operating income, net in the 2022 periods primarily reflected rebates ($1.2 million in the second-quarter and $2.2 million in the first six months) and royalty income ($0.5 million in the second quarter and $0.9 million in the first six months).

Other operating income, net in the 2021 periods primarily reflected rebates ($0.8 million in the second-quarter and $1.7 million in the first six months) and royalty income ($0.4 million in the second quarter and $0.7 million in the first six months), partially offset by an insurance settlement of $0.5 million in both the second quarter and first six months at CCM.

Operating Income

(in millions)

2022 Three Months Ended June 30, 2021 Change% 2022 Six Months Ended June 30, 2021 Change%
Operating income $410.6 $133.8 $276.8 206.9% $687.9 $218.5 $469.4 214.8%
Operating margin percentage 22.2% 11.4% 20.6% 10.3%

Refer to Segment Results of Operations within this MD&A for further information related to segment operating income results.

Interest Expense, net

(in millions)

2022 Three Months Ended June 30, 2021 Change% 2022 Six Months Ended June 30, 2021 Change%
Interest expense, net $22.4 $19.2 $3.2 16.7% $45.0 $38.4 $6.6 17.2%

Interest expense, net of capitalized interest, increased in the second quarter and the first six months of 2022 primarily reflecting higher long-term debt balances associated with our public offering of $550.0 million of 2.20% unsecured senior notes and $300.0 million of 0.55% unsecured senior notes completed in September 2021. Refer to Note 12 for further information on our long-term debt.

Interest Income

(in millions)

2022 Three Months Ended June 30, 2021 Change% 2022 Six Months Ended June 30, 2021 Change%
Interest income $(0.6) $(0.4) $(0.2) 50.0% $(0.8) $(0.9) $0.1 (11.1)%

Interest income increased during the second quarter of 2022 primarily reflecting higher yields.

Other Non-operating Expense, net

(in millions)

2022 Three Months Ended June 30, 2021 Change% 2022 Six Months Ended June 30, 2021 Change%
Other non-operating expense, net $2.5 $1.1 $1.4 NM $2.6 $4.7 $(2.1) NM

Other non-operating expense, net, in the second quarter and the first six months of 2022 primarily reflected unrealized losses on Rabbi Trust investments and changes in foreign currencies against the U.S. Dollar.

Other non-operating expense, net in the first six months of 2021 primarily reflected the release of a portion of the indemnification asset related to the Petersen Aluminum Corporation ("Petersen") acquisition resulting from escrow expirations and changes in foreign currencies against the U.S. Dollar.

Income Taxes

(in millions)

2022 Three Months Ended June 30, 2021 Change% 2022 Six Months Ended June 30, 2021 Change%
Provision for income taxes $90.4 $19.8 $70.6 356.6% $150.9 $33.1 $117.8 355.9%
Effective tax rate 23.4% 17.4% 23.5% 18.8%

The effective income tax rate on continuing operations for the first six months of 2022 was 23.5%. The year-to-date provision for income taxes included taxes on earnings at an anticipated rate of 23.8% and a tax impact of $1.7 million related to discrete activity.

The effective income tax rate on continuing operations for the first six months of 2021 was 18.8%.

Income from Discontinued Operations

(in millions)

2022 Three Months Ended June 30, 2021 Change% 2022 Six Months Ended June 30, 2021 Change%
Income from discontinued operations before income taxes $4.8 $6.3 $(1.5) NM $4.1 $10.8 $(6.7) NM
(Benefit from) provision for income taxes (0.8) 1.1 (0.8) 2.5
Income from discontinued operations $5.6 $5.2 $4.9 $8.3

Income from discontinued operations in the second quarter and the first six months of 2022 primarily reflects a gain on the sale of real estate associated with the 2021 sale of the equity interests and assets comprising the Carlisle Brake & Friction ("CBF") segment. Income from discontinued operations in the second quarter and the first six months of 2021 reflects the operating results from the CBF segment, partially offset by pre-closing transaction expenses.

Segment Results of Operations

Carlisle Construction Materials

This segment produces a complete line of premium energy-efficient single-ply roofing products and warranted roof systems and accessories for the commercial building industry, including EPDM, TPO and PVC membrane, polyiso insulation, and engineered metal roofing and wall panel systems for commercial and residential buildings.

(in millions)

2022 Three Months Ended June 30, 2021 Change% Acquisition Effect Price / Volume Effect Exchange Rate Effect
Revenues $1,113.4 $722.8 $390.6 54.0% —% 54.9% (0.9)%
Operating income $358.9 $155.0 $203.9 131.5%
Operating margin 32.2% 21.4%
Adjusted EBITDA(1) $371.3 $168.3 $203.0 120.6%
Adjusted EBITDA margin(1) 33.3% 23.3%

(in millions)

2022 Six Months Ended June 30, 2021 Change% Acquisition Effect Price / Volume Effect Exchange Rate Effect
Revenues $1,994.5 $1,279.2 $715.3 55.9% —% 56.6% (0.7)%
Operating income $620.0 $265.7 $354.3 133.3%
Operating margin 31.1% 20.8%
Adjusted EBITDA(1) $646.6 $292.2 $354.4 121.3%
Adjusted EBITDA margin(1) 32.4% 22.8%

(1) Adjusted EBITDA and adjusted EBITDA margin are intended to provide investors and others with information about Carlisle and its segments' performance without the effect of items that, by their nature, tend to obscure core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for more information about, and a detailed reconciliation of these items.

CCM’s revenue increased in the second quarter and the first six months of 2022 primarily reflecting positive pricing across all product lines and the strength of U.S. commercial roofing demand.

CCM’s operating margin and adjusted EBITDA margin increase in the second quarter and the first six months of 2022 primarily reflected positive pricing, higher volumes, favorable product mix, and savings from Carlisle Operating System ("COS"), partially offset by raw material, freight and wage inflation.

Carlisle Weatherproofing Technologies

This segment produces building envelope solutions that effectively drive energy efficiency and sustainability in commercial and residential applications. Products include high-performance waterproofing and moisture protection products, protective roofing underlayments, fully integrated liquid and sheet applied air/vapor barriers, sealants/primers and flashing systems, roof coatings and mastics, spray polyurethane foam and coating systems for a wide variety of thermal protection applications and other premium polyurethane products, block-molded expanded polystyrene insulation, engineered products for HVAC applications, and premium rubber products for a variety of industrial and surfacing applications.

(in millions)

2022 Three Months Ended June 30, 2021 Change% Acquisition Effect Price / Volume Effect Exchange Rate Effect
Revenues $448.9 $214.5 $234.4 109.3% 85.3% 24.4% (0.4)%
Operating income $59.0 $22.4 $36.6 163.4%
Operating margin 13.1% 10.4%
Adjusted EBITDA(1) $83.5 $32.9 $50.6 153.8%
Adjusted EBITDA margin(1) 18.6% 15.3%

(in millions)

2022 Six Months Ended June 30, 2021 Change% Acquisition Effect Price / Volume Effect Exchange Rate Effect
Revenues $808.0 $377.4 $430.6 114.1% 85.0% 29.4% (0.3)%
Operating income $96.5 $33.0 $63.5 192.4%
Operating margin 11.9% 8.7%
Adjusted EBITDA(1) $146.6 $53.8 $92.8 172.5%
Adjusted EBITDA margin(1) 18.1% 14.3%

(1) Adjusted EBITDA and adjusted EBITDA margin are intended to provide investors and others with information about Carlisle and its segments' performance without the effect of items that, by their nature, tend to obscure core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for more information about, and a detailed reconciliation of these items.

CWT’s revenue increased in the second quarter and the first six months of 2022 primarily reflecting contributions from the Henry acquisition, positive pricing and strength across all our product lines.

CWT’s operating margin and adjusted EBITDA margin increase in the second quarter and the first six months of 2022 primarily reflected positive pricing, contributions from the Henry acquisition, higher volumes, favorable product mix and savings from COS, partially offset by raw material, freight and wage inflation.

Carlisle Interconnect Technologies

This segment produces high-performance wire and cable, including optical fiber, for the commercial aerospace, military and defense electronics, medical device, industrial, and test and measurement markets. CIT's product portfolio also includes sensors, connectors, contacts, cable assemblies, complex harnesses, racks, trays, and installation kits, in addition to engineering and certification services. CIT also provides medical device products and solutions for several medical technology applications.

During the third quarter of 2021, we announced the closure of our manufacturing operations in Carlsbad, California, and the relocation of those operations to our existing facilities in North America. The project is estimated to take a remaining six to nine months to complete. Total projected costs are expected to approximate $5.8 million, with approximately $2.6 million costs remaining to be incurred.

(in millions)

2022 Three Months Ended June 30, 2021 Change% Acquisition Effect Price / Volume Effect Exchange Rate Effect
Revenues $212.6 $168.9 $43.7 25.9% —% 26.1% (0.2)%
Operating income (loss) $7.9 $(12.9) $20.8 NM
Operating margin 3.7% (7.6)%
Adjusted EBITDA(1) $27.0 $13.5 $13.5 100.0%
Adjusted EBITDA margin(1) 12.7% 8.0%

(in millions)

2022 Six Months Ended June 30, 2021 Change% Acquisition Effect Price / Volume Effect Exchange Rate Effect
Revenues $397.6 $324.7 $72.9 22.5% —% 22.5% —%
Operating income (loss) $5.4 $(23.6) $29.0 NM
Operating margin 1.4% (7.3)%
Adjusted EBITDA(1) $45.4 $24.5 $20.9 85.3%
Adjusted EBITDA margin(1) 11.4% 7.5%

(1) Adjusted EBITDA and adjusted EBITDA margin is intended to provide investors and others with information about Carlisle's and its segments' performance without the effect of items that, by their nature, tend to obscure core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for more information about, and a detailed reconciliation of these items.

CIT’s revenue increased in the second quarter and the first six months of 2022 primarily reflected continued strengthening of aerospace and medical end markets.

CIT’s operating margin and adjusted EBITDA margin increase in the second quarter and the first six months of 2022 primarily reflected higher volumes, positive pricing, and savings from COS, partially offset by raw material and wage inflation, unfavorable product mix and higher operating expenses.

Carlisle Fluid Technologies

This segment produces highly engineered liquid, powder, sealants and adhesives finishing equipment and integrated system solutions for spraying, pumping, mixing, metering and curing of a variety of coatings used in the automotive manufacture, general industrial, protective coating, wood, specialty and automotive refinishing markets.

(in millions)

2022 Three Months Ended June 30, 2021 Change% Acquisition Effect Price / Volume Effect Exchange Rate Effect
Revenues $72.0 $71.6 $0.4 0.6% —% 5.5% (4.9)%
Operating income $7.0 $6.6 $0.4 6.1%
Operating margin 9.7% 9.2%
Adjusted EBITDA(1) $12.2 $11.4 $0.8 7.0%
Adjusted EBITDA margin(1) 16.9% 15.9%

(in millions)

2022 Six Months Ended June 30, 2021 Change% Acquisition Effect Price / Volume Effect Exchange Rate Effect
Revenues $143.1 $137.4 $5.7 4.1% —% 7.5% (3.4)%
Operating income $11.8 $10.9 $0.9 8.3%
Operating margin 8.2% 7.9%
Adjusted EBITDA(1) $22.7 $21.6 $1.1 5.1%
Adjusted EBITDA margin(1) 15.9% 15.7%

(1) Adjusted EBITDA and adjusted EBITDA margin is intended to provide investors and others with information about Carlisle's and its segments' performance without the effect of items that, by their nature, tend to obscure core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for more information about, and a detailed reconciliation of these items.

CFT’s revenue increase in the second quarter and the first six months of 2022 primarily reflected positive pricing, partially offset by unfavorable changes in foreign currency rates.

CFT’s operating margin and adjusted EBITDA margin increase in the second quarter and the first six months of 2022 primarily reflected positive pricing and savings from COS, partially offset by raw material and wage inflation.

Liquidity and Capital Resources

A summary of our cash and cash equivalents by region follows:

(in millions)

June 30, 2022 December 31, 2021
Europe $65.1 $12.3
North America (excluding U.S.) 36.3 40.8
China 24.1 17.8
Asia Pacific (excluding China) 35.5 12.9
International cash and cash equivalents 161.0 83.8
U.S. cash and cash equivalents 192.2 240.6
Total cash and cash equivalents $353.2 $324.4

We maintain liquidity sources primarily consisting of cash and cash equivalents as well as availability under the Company's Fourth Amended and Restated Credit Agreement (as amended, the "Facility"). In the near term, cash on hand is our primary source of liquidity. The increase in cash and cash equivalents compared to December 31, 2021, is primarily related to cash generated from operations and the receipt of the $125 million earn out payment from the sale of CBF, partially offset by share repurchases, capital expenditures and payment of dividends to stockholders.

In certain countries, primarily China, our cash is subject to local laws and regulations that require government approval for conversion of such cash to U.S. Dollars, as well as for transfer of such cash, both temporarily and permanently outside of that jurisdiction. In addition, upon permanent transfer of cash outside of certain jurisdictions, primarily in Canada and China, we may be subject to withholding taxes, and as such we have accrued $7.9 million in anticipation of those taxes as of June 30, 2022.

We believe we have sufficient cash on hand, availability under the Facility and operating cash flows to meet our anticipated business requirements for at least the next 12 months. At the discretion of management, the Company may use available cash on capital expenditures, dividends, common stock repurchases, acquisitions and strategic investments.

We also anticipate we will have sufficient cash on hand, availability under the Facility and operating cash flows to meet our anticipated long-term business requirements and to pay outstanding principal balances of our existing notes by the respective maturity dates. Another potential source of liquidity is access to public capital markets, subject to market conditions. We may access the capital markets for a variety of reasons, including to repay the outstanding balances of our outstanding debt and fund acquisitions. Refer to Note 12.

Sources and Uses of Cash and Cash Equivalents

(in millions)

Six Months Ended June 30, 2022 2021
Net cash provided by operating activities $223.5 $171.5
Net cash provided by (used in) investing activities 36.9 (63.5)
Net cash used in financing activities (229.9) (284.5)
Effect of foreign currency exchange rate changes on cash (1.7) (0.3)
Change in cash and cash equivalents $28.8 $(176.8)

Operating Activities

We generated operating cash flows of $223.5 million for the first six months of 2022 (including working capital uses of $415.8 million), compared with $171.5 million for the first six months of 2021 (including working capital uses of $103.9 million). Higher operating cash flows for the first six months of 2022 primarily reflected higher net income, partially offset by higher working capital uses related to an increase in receivables from higher sales and an increase in inventory from rising raw material costs and increased volume, partially offset by higher payables due to rising raw material costs.

Investing Activities

Cash provided by investing activities of $36.9 million for the first six months of 2022 primarily reflected the proceeds of the contingent consideration from the earn out payment and sale of real estate associated with the 2021 sale of CBF of $132.0 million and proceeds from investment in securities of $10.3 million, partially offset by capital expenditures of $82.7 million and the acquisition of MBTechnology for $24.7 million. Cash used in investing activities of $63.5 million for the first six months of 2021 primarily reflected capital expenditures of $55.1 million and investment in securities of $10.2 million.

Financing Activities

Cash used in financing activities of $229.9 million in the first six months of 2022 primarily reflected share repurchases of $175.0 million and cash dividend payments of $56.7 million, reflecting the increased quarterly dividend of $0.54 per share. Cash used in financing activities of $284.5 million during the first six months of 2021 primarily reflected share repurchases of $265.6 million and dividend payments of $56.0 million.

Debt Instruments

Senior Notes

We have unsecured senior notes outstanding of $350.0 million due November 15, 2022 (at a stated interest rate of 3.75%). We anticipate using cash on hand, availability under the Facility and operating cash flows as potential sources to repay these notes upon maturity.

Revolving Credit Facility

During the first six months of 2022 and 2021, we had no borrowings or repayments under the Facility. As of June 30, 2022 and December 31, 2021, the Facility had no outstanding balance and $1.0 billion available for use.

Debt Covenants

We are required to meet various covenants and limitations under our senior notes and Facility, including certain leverage ratios, interest coverage ratios and limits on outstanding debt balances held by certain subsidiaries. We were in compliance with all covenants and limitations as of June 30, 2022 and December 31, 2021.

Refer to Note 12 for further information on our debt instruments.

Non-GAAP Financial Measures

EBIT, Adjusted EBIT, Adjusted EBITDA and Adjusted EBITDA Margin

Earnings before interest and taxes ("EBIT"), adjusted EBIT, adjusted earnings before interest, taxes, depreciation and amortization ("EBITDA") and adjusted EBITDA margin are intended to provide investors and others with information about the Company's and its segments' performance without the effect of items that, by their nature, tend to obscure core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. As a result, management believes that these measures enhance the ability of investors to analyze trends in the Company’s business and evaluate the Company’s performance relative to similarly-situated companies. This information differs from net income, operating income, and operating margin determined in accordance with accounting principles generally accepted in the United States of America ("GAAP") and should not be considered in isolation or as a substitute for measures of performance determined in accordance with GAAP. The Company's and its segments' EBIT, adjusted EBIT, adjusted EBITDA and adjusted EBITDA margin follows. These non-GAAP financial measures may not be comparable to similarly titled measures reported by other companies.

(in millions)

Three Months Ended June 30, 2022 2021 Six Months Ended June 30, 2022 2021
Net income (GAAP) $301.5 $99.3 $495.1 $151.5
Less: income from discontinued operations (GAAP) 5.6 5.2 4.9 8.3
Income from continuing operations (GAAP) 295.9 94.1 490.2 143.2
Provision for income taxes 90.4 19.8 150.9 33.1
Interest expense, net 22.4 19.2 45.0 38.4
Interest income (0.6) (0.4) (0.8) (0.9)
EBIT 408.1 132.7 685.3 213.8
Exit and disposal, and facility rationalization costs 0.7 7.5 2.8 10.6
Inventory step-up amortization and transaction costs 0.8 1.3 0.8 2.2
Impairment charges — — 0.2 —
Losses from acquisitions and disposals 0.1 0.1 0.4 3.5
Losses from insurance — 0.5 0.3 0.5
Losses from litigation — 0.1 — 0.1
Total non-comparable items 1.6 9.5 4.5 16.9
Adjusted EBIT 409.7 142.2 689.8 230.7
Depreciation 24.0 20.3 48.0 40.6
Amortization 38.5 29.2 79.2 58.2
Adjusted EBITDA $472.2 $191.7 $817.0 $329.5
Divided by:
Total revenues $1,846.9 $1,177.8 $3,343.2 $2,118.7
Adjusted EBITDA margin 25.6% 16.3% 24.4% 15.6%

30

(in millions)

Three Months Ended June 30, 2022 CCM CWT CIT CFT Corporate and unallocated
Operating income (loss) (GAAP) $358.9 $59.0 $7.9 $7.0 $(22.2)
Non-operating expense (income)(1) 0.9 0.1 (0.3) — 1.8
EBIT 358.0 58.9 8.2 7.0 (24.0)
Exit and disposal, and facility rationalization costs — — 0.7 — —
Inventory step-up amortization and transaction costs — 0.1 — — 0.7
(Gains) losses from acquisitions and disposals (0.1) — 0.2 — —
(Gains) losses from litigation — — (0.1) — 0.1
Total non-comparable items (0.1) 0.1 0.8 — 0.8
Adjusted EBIT 357.9 59.0 9.0 7.0 (23.2)
Depreciation 9.3 6.4 6.1 1.4 0.8
Amortization 4.1 18.1 11.9 3.8 0.6
Adjusted EBITDA $371.3 $83.5 $27.0 $12.2 $(21.8)
Divided by:
Total revenues $1,113.4 $448.9 $212.6 $72.0 $—
Adjusted EBITDA margin 33.3% 18.6% 12.7% 16.9% NM

(1) Includes other non-operating (income) expense, which may be presented in separate line items on the Condensed Consolidated Statements of Income and Comprehensive Income.

(in millions)

Three Months Ended June 30, 2021 CCM CWT CIT CFT Corporate and unallocated
Operating income (loss) (GAAP) $155.0 $22.4 $(12.9) $6.6 $(37.3)
Non-operating expense (income)(1) — 0.1 — 1.1 (0.1)
EBIT 155.0 22.3 (12.9) 5.5 (37.2)
Exit and disposal, and facility rationalization costs — — 7.7 (0.2) —
Inventory step-up amortization and transaction costs — — — — 1.3
(Gains) losses from acquisitions and disposals (0.1) — — 0.2 —
Losses from insurance 0.3 0.2 — — —
Losses from litigation — — — — 0.1
Total non-comparable items 0.2 0.2 7.7 — 1.4
Adjusted EBIT 155.2 22.5 (5.2) 5.5 (35.8)
Depreciation 9.1 2.9 6.0 1.4 0.9
Amortization 4.0 7.5 12.7 4.5 0.5
Adjusted EBITDA $168.3 $32.9 $13.5 $11.4 $(34.4)
Divided by:
Total revenues $722.8 $214.5 $168.9 $71.6 $—
Adjusted EBITDA margin 23.3% 15.3% 8.0% 15.9% NM

(1) Includes other non-operating (income) expense, which may be presented in separate line items on the Condensed Consolidated Statements of Income and Comprehensive Income.

(in millions)

Six Months Ended June 30, 2022 CCM CWT CIT CFT Corporate and unallocated
Operating income (loss) (GAAP) $620.0 $96.5 $5.4 $11.8 $(45.8)
Non-operating expense (income)(1) 0.9 0.2 (0.8) 0.1 2.2
EBIT 619.1 96.3 6.2 11.7 (48.0)
Exit and disposal, and facility rationalization costs — 0.1 2.7 — —
Inventory step-up amortization and transaction costs — — — — 0.8
Impairment charges — 0.2 — — —
(Gains) losses from acquisitions and disposals (0.1) — 0.4 0.1 —
Losses from insurance — 0.3 — — —
(Gains) losses from litigation — — (0.1) — 0.1
Total non-comparable items (0.1) 0.6 3.0 0.1 0.9
Adjusted EBIT 619.0 96.9 9.2 11.8 (47.1)
Depreciation 18.5 12.7 12.2 2.9 1.7
Amortization 9.1 37.0 24.0 8.0 1.1
Adjusted EBITDA $646.6 $146.6 $45.4 $22.7 $(44.3)
Divided by:
Total revenues $1,994.5 $808.0 $397.6 $143.1 $—
Adjusted EBITDA margin 32.4% 18.1% 11.4% 15.9% NM

(1) Includes other non-operating expense (income), which may be presented in separate line items on the Condensed Consolidated Statements of Income and Comprehensive Income.

(in millions)

Six Months Ended June 30, 2021 CCM CWT CIT CFT Corporate and unallocated
Operating income (loss) (GAAP) $265.7 $33.0 $(23.6) $10.9 $(67.5)
Non-operating expense(1) 2.3 — — 1.5 0.9
EBIT 263.4 33.0 (23.6) 9.4 (68.4)
Exit and disposal, and facility rationalization costs — — 10.2 0.4 —
Inventory step-up amortization and transaction costs — — — 0.1 2.1
Losses from acquisitions and disposals 2.2 — 0.3 0.2 0.8
Losses from insurance 0.3 0.2 — — —
Losses from litigation — — — — 0.1
Total non-comparable items 2.5 0.2 10.5 0.7 3.0
Adjusted EBIT 265.9 33.2 (13.1) 10.1 (65.4)
Depreciation 18.3 5.6 12.3 2.6 1.8
Amortization 8.0 15.0 25.3 8.9 1.0
Adjusted EBITDA $292.2 $53.8 $24.5 $21.6 $(62.6)
Divided by:
Total revenues $1,279.2 $377.4 $324.7 $137.4 $—
Adjusted EBITDA margin 22.8% 14.3% 7.5% 15.7% NM

(1) Includes other non-operating expense (income), which may be presented in separate line items on the Condensed Consolidated Statements of Income and Comprehensive Income.

Outlook

Our expectations for segment and total revenues for 2022, compared to 2021 follow:

2022 Revenue Primary Drivers
Carlisle Construction Materials ~40% growth •Proactive pricing measures gaining traction •Strong re-roofing demand •Increasing demand for energy-efficient building products
Carlisle Weatherproofing Technologies ~60% growth •Henry acquisition •Strong demand in all product lines
Carlisle Interconnect Technologies ~20% growth •Growing commercial aerospace and medical backlogs
Carlisle Fluid Technologies ~10% growth •Focus on new product introductions and price discipline •Markets strengthening
Total Carlisle Over 40% growth

For the year 2022, we expect:

  • Corporate expenses of approximately $110 million;
  • Depreciation and amortization expense of approximately $250 million;
  • Capital expenditures of approximately $175 million;
  • Interest expense, net of interest income, of approximately $90 million; and
  • Base tax rate of approximately 24-25%.

Forward-Looking Statements

This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the potential or expected impacts of the global COVID-19 pandemic. Forward-looking statements generally use words such as "expect," "foresee," "anticipate," "believe," "project," "should," "estimate," "will," "plans," "intends," "forecast," and similar expressions, and reflect our expectations concerning the future. Such statements are made based on known events and circumstances at the time of publication and, as such, are subject in the future to unforeseen risks and uncertainties. It is possible that our future performance may differ materially from current expectations expressed in these forward-looking statements, due to a variety of factors such as: risks from the global COVID-19 pandemic, including, for example, expectations regarding the impact of the COVID-19 pandemic on our businesses, including on customer demand, supply chains and distribution systems, production, our ability to maintain appropriate labor levels, our ability to ship products to our customers, our future results, or our full-year financial outlook; increasing price and product/service competition by foreign and domestic competitors, including new entrants; technological developments and changes; the ability to continue to introduce competitive new products and services on a timely, cost-effective basis; our mix of products/services; increases in raw material costs that cannot be recovered in product pricing; domestic and foreign governmental and public policy changes including environmental and industry regulations; threats associated with and efforts to combat terrorism; protection and validity of patent and other intellectual property rights; the identification of strategic acquisition targets and our successful completion of any transaction and integration of our strategic acquisitions; our successful completion of strategic dispositions; the cyclical nature of our businesses; the impact of information technology, cybersecurity or data security breaches at our businesses or third parties; and the outcome of pending and future litigation and governmental proceedings; and the other factors discussed in the reports we file with or furnish to the Securities and Exchange Commission from time to time. In addition, such statements could be affected by general industry and market conditions and growth rates, the condition of the financial and credit markets and general domestic and international economic conditions, including inflation and interest rate and currency exchange rate fluctuations. Further, any conflict in the international arena, including the Russian invasion of Ukraine, may adversely affect general market conditions and our future performance. Any forward-looking statement speaks only as of the date on which that statement is made, and we undertake no duty to update any forward-looking statement to reflect events or circumstances, including unanticipated events, after the date on which that statement is made, unless otherwise required by law. New factors emerge from time to time and it is not possible for management to predict all of those factors, nor can it assess the impact of each of those factors on the business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statement.

Market risk

As filed, 269 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes in the Company’s market risk for the six months ended June 30, 2022. For additional information, refer to "PART II—Item 7A. Quantitative and Qualitative Disclosures About Market Risk" of the Company’s 2021 Annual Report on Form 10-K.

Controls and procedures

As filed, 1,721 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

a. Evaluation of disclosure controls and procedures. Under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, the Company carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Exchange Act Rule 13a-15. Based upon that evaluation and as of June 30, 2022, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective.

b. Changes in internal controls. During third quarter of 2021, the Company completed its acquisition of ASP Henry Holdings, Inc. (“Henry”). This acquisition is material to the Company's results of operations, financial position and cash flows. Refer to Note 3 for additional information regarding the Henry acquisition.

The Company is currently in the process of integrating Henry, including internal controls and procedures and extending its Sarbanes-Oxley Act Section 404 compliance program to include Henry. The Company anticipates a successful integration of Henry's operations and internal controls and procedures and will continue to evaluate its internal control over financial reporting as the Company executes integration activities. The Company's assessment of the effectiveness of controls and procedures for the year ended December 31, 2022, will include Henry.

During the first the first six months of months of 2022, there were no changes in the Company's internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

Risk factors

As filed, 149 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes in the Company's risk factors disclosed in "PART I—Item 1A. Risk Factors" in our 2021 Annual Report on Form 10-K.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-04-01 to 2022-06-30$1.85bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2022-01-01 to 2022-06-30$3.34bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2022-04-01 to 2022-06-30$1.21bnus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2022-01-01 to 2022-06-30$2.22bnus-gaap:CostOfGoodsAndServicesSold
Research and development3 months2022-04-01 to 2022-06-30$12.6mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2022-01-01 to 2022-06-30$24.9mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2022-04-01 to 2022-06-30$210.6mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2022-01-01 to 2022-06-30$413.6mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2022-04-01 to 2022-06-30$410.6mus-gaap:OperatingIncomeLoss
Operating income6 months2022-01-01 to 2022-06-30$687.9mus-gaap:OperatingIncomeLoss
Interest expense3 months2022-04-01 to 2022-06-30$22.4mus-gaap:InterestExpense
Interest expense6 months2022-01-01 to 2022-06-30$45.0mus-gaap:InterestExpense
Income tax3 months2022-04-01 to 2022-06-30$90.4mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2022-01-01 to 2022-06-30$150.9mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-04-01 to 2022-06-30$301.5mus-gaap:NetIncomeLoss
Net income6 months2022-01-01 to 2022-06-30$495.1mus-gaap:NetIncomeLoss
Diluted EPS3 months2022-04-01 to 2022-06-30$5.73us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2022-01-01 to 2022-06-30$9.37us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-04-01 to 2022-06-30$5.81us-gaap:EarningsPerShareBasic
Basic EPS6 months2022-01-01 to 2022-06-30$9.50us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-04-01 to 2022-06-3052,500,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2022-01-01 to 2022-06-3052,700,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2022-01-01 to 2022-06-30$223.5mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2022-01-01 to 2022-06-30$82.7mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2022-01-01 to 2022-06-30$56.7mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases6 months2022-01-01 to 2022-06-30$175.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Current assetsAt period end2022-06-30$2.53bnus-gaap:AssetsCurrent
Total assetsAt period end2022-06-30$7.58bnus-gaap:Assets
Current liabilitiesAt period end2022-06-30$1.26bnus-gaap:LiabilitiesCurrent
Long-term debtAt period end2022-06-30$2.58bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2022-06-30$352.2mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2022-06-30$2.88bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000790051-22-000146. Last ingested by Listed: Nov 10, 2026, 16:42 ET. Listed shows no prices and gives no investment advice.